2-(4-(BENZYLOXY)PHENYL)-3-METHYLBUTANOIC ACID, 95.0%, 5g

NHS C3 azides, ≥95%, 5 mg, plastic packaging.

Tert-butyl 3-(2-oxopyrrolidin-1-yl)azetidine-1-carboxylate, 98%, 250mg

2-((tert-Butyldiphenylsilyl)oxy)acetic acid, 95.0%, 100mg

6-Amino-3-bromo-2-methylpyridine>98.0%(GC)(T)5g

3-[(1S)-1-aminoethyl]-benzonitrile, 98%, 250mg

N-(3-Methoxypropyl)-N?-propylurea, 1g

2-Methyl-6-nitrobenzoic acid, 98.0%, 100g

3-chloro-4-fluoro-2'-(4-methylpiperazinomethyl) benzophenone, 97.0%, 1g

(S)-3-((tert-Butoxycarbonyl)amino)-3-(4-(trifluoromethyl)phenyl)propanoic acid, 95.0%, 10g

3,3,3-Trifluoro-2,2-dimethylpropionic acid, 97.0%, 1g

4-bromo-1,2-oxazol-3-ol, 95.0%, 250mg

(Fmoc-amino)-PEG6-carboxylic Acid>98.0%(HPLC)(T)250mg